MPSC has cancelled the Drug Inspector Group-B recruitment process after a preliminary inquiry found prima facie evidence that a candidate received the question set before the March 22 screening exam and benefited from it. The Commission will conduct a fresh examination without requiring candidates to reapply or pay a fee.
Mumbai: The Maharashtra Public Service Commission (MPSC) has decided to cancel the recruitment process conducted for the post of Drug Inspector, Group-B in the Food and Drug Administration Department, an official said.
This decision was taken in the background of a preliminary inquiry conducted after complaints were received regarding alleged malpractice in the screening examination held on March 22.
After the Commision has published an advertisement for the post of Drug Inspector on July 29, 2025, the screening examination was conducted offline on March 22 at six divisional headquarters in the state. The result of this examination was declared on June 12. After the screening examination, 506 candidates were found eligible for the interview. Out of them, interviews of 488 candidates were conducted from July 1 to 22.
After the completion of interviews on July 22, a provisional general merit list of a total of 488 candidates, including 485 eligible and three ineligible for the post of Drug Inspector, was published on the Commission's website.
-
Candles don’t tunnel when you use £1 reusable item
-
Preity Zinta Declares She Is Team Tukaram Mundhe With A Bold Fashion Statement
-
Vande Bharat Safety: Even at a speed of 160, the train will stop automatically after sensing danger, safety increased with Kavach 4.0
-
Ai+ Nova 2 Power: Will be launched soon with 7,000mAh battery and Dimensity 7100, know the features
-
Fatima was punished for being rude, Pakistan is disgraced again in international cricket
